Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$624.21 USD
+3.79 (0.61%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $623.39 -0.82 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Price, Consensus and EPS Surprise
TMO 624.21 +3.79(0.61%)
Will TMO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TMO
The Zacks Analyst Blog Highlights JPMorgan Chase, Thermo Fisher, Arista Networks, United Homes Group and GSI
Top Research Reports for JPMorgan, Thermo Fisher & Arista Networks
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Thermo Fisher (TMO) Up 1.6% Since Last Earnings Report?
Reasons to Retain Thermo Fisher (TMO) in Your Portfolio Now
Top Analyst Reports for Apple, NVIDIA & Coca-Cola
Other News for TMO
Dividend Champion, Contender, And Challenger Highlights: Week Of September 8
Election 2024: Where To Put Your Money Ahead of the Vote
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity
Thermo Fisher Scientific (TMO) presents at Morgan Stanley 22nd Annual Global Healthcare Conference - Conference Call Transcript
Russell companies with the lowest tax rates expected to generate $1B in 2025 – GS